Long-Term Results of Melphalan-Based Isolated Limb Perfusion With or Without Low-Dose TNF for In-Transit Melanoma Metastases

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

Mahesh Parmar, Valter Torri, Lesley Stewart · Statistics in Medicine · 1998 · 4.8K citations

Public Health, Biostatistics, Epidemiology +8

Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions

J Wieberdink, C. Benckhuysen, R. P. Braat et al. · European Journal of Cancer and Clinical Oncology · 1982 · 458 citations

Medicine, Pharmacology, Toxicology +14

Bleomycin-Based Electrochemotherapy: Clinical Outcome from a Single Institution’s Experience with 52 Patients

L Campana, Simone Mocellin, Michela Basso et al. · Annals of Surgical Oncology · 2008 · 289 citations

Pharmacy, Pharmacotherapy, Drug Delivery +4

Randomized Multicenter Trial of Hyperthermic Isolated Limb Perfusion With Melphalan Alone Compared With Melphalan Plus Tumor Necrosis Factor: American College of Surgeons Oncology Group Trial Z0020

Wendy R. Cornett, Linda McCall, Rebecca P. Petersen et al. · Journal of Clinical Oncology · 2006 · 221 citations

Medicine, Oncology, Pharmacology +16

Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necrosis factor dose-escalation study.

Douglas L. Fraker, H. Richard Alexander, Mary P. Andrich et al. · Journal of Clinical Oncology · 1996 · 212 citations

Medicine, Oncology, Pharmacotherapy +17